Size frequency distributions of the florid prion protein aggregates in variant Creutzfeldt-Jakob disease follow a power-law function

Neurological Sciences

Volumn 27, Issue 2, 2006, Pages 104-109

  Armstrong, R A ^a   Cairns, N J ^b   Ironside, J W ^c  

^a ASTON UNIVERSITY   (United Kingdom)

^b WASHINGTON UNIVERSITY   (United States)

^c WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Diffuse plaque; Florid plaque; Power law function; Prion protein aggregates; Size distribution; Variant Creutzfeldt Jakob disease

Indexed keywords

PRION PROTEIN;

ADULT; ARTICLE; BRAIN CORTEX; BRAIN TISSUE; CLINICAL ARTICLE; CLINICAL FEATURE; CORRELATION COEFFICIENT; CREUTZFELDT JAKOB DISEASE; FEMALE; HIPPOCAMPUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MORPHOMETRICS; MORTALITY; NEUROPATHOLOGY; PATHOGENESIS; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; BRAIN; CREUTZFELDT-JAKOB SYNDROME; FEMALE; HUMANS; MALE; MIDDLE AGED; PRIONS; RETROSPECTIVE STUDIES;

EID: 33745604012     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10072-006-0608-9     Document Type: Article

References (19)

1. Armstrong RA, Lantos PL, Cairns NJ (2001) The spatial patterns of prion protein deposits in Creutzfeldt-Jakob disease: Comparison with β-amyloid deposits in Alzheimer's disease. Neurosci Lett 298:53-56
2. Armstrong RA, Myers D, Smith CUM (1991) Alzheimer's disease: Size class frequency distributions of senile plaques: Do they indicate when a brain region was affected? Neurosci Lett 127:223-226
3. Armstrong RA (1999) Do β-amyloid (Aβ) deposits in patients with Alzheimer's disease and Down's syndrome grow according to the log-normal model? Neurosci Lett 261:97-100
4. Li GY, Zhou P, Shao ZZ et al (2001) The natural silk spinning process: A nucleation-dependent aggregation mechanism. Eur J Biochem 268:6600-6606
5. Stanley HE, Buldyrev SV, Cruz L et al (1998) Statistical physics and Alzheimer's disease. Physica A 249:460-471
6. Armstrong RA, Lantos PL, Ironside JW, Cairns NJ (2003) Differences in the density and spatial distribution of florid and diffuse plaques in variant Creutzfeldt-Jakob disease (vCJD). Clin Neuropath 22:209-214
7. Urbanc B, Cruz L, Buldyrev SV et al (1999) Dynamics of plaque formation in Alzheimer's disease. Biophys J 76:1330-1334
8. Kalaria RN, Kroon SN, Perry G (1993) Serum proteins and the blood-brain barrier in the pathogenesis of Alzheimer's disease. In: Nicolini M, Zatta PF, Corain B (eds) Alzheimer's disease and related disorders, Advances in Biosciences 87. Pergamon Press, UK, pp 281-282
9. Saunders AM, Strittmatter WJ, Schmechel D et al (1993) Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43:1467-1472
10. Will R, Ironside JW, Zeidler M et al (1996) A new variant of Creutzfeldt-Jakob disease in the United Kingdom. Lancet 347:921-925
11. Ironside JW, Head MW, Bell JE et al (2000) Laboratory diagnosis of variant Creutzfeldt-Jakob disease. Histopathology 37:1-9
12. Hill AF, Butterworth RJ, Joiner S et al (1999) Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet 353:183-189
13. Krasemann S, Groschup MH, Harmeyer S et al (1996) Generation of monoclonal antibodies against human prion proteins in PrPO/O mice. Mol Med 2:725-734
14. McLean CA, Ironside JW, Alpers MP et al (1998) Comparative neuropathology of kuru with new variant of Creutzfeldt-Jakob disease: evidence for strain of agent predominating over genotype of host. Brain Pathol 8:429-437
15. Armstrong RA, Cairns NJ, Ironside JW, Lantos PL (2002) Laminar distribution of the pathological changes in the cerebral cortex in variant Creutzfeldt-Jakob disease (vCJD). Folia Neuropathol 40:165-171
16. Tashima T, Kitamoto T, Tateishi J, Sato Y (1986) Congophilia in cerebral amyloidosis is modified by inactivation procedures on slow transmissible pathogens. Brain Res 399:80-86
17. Harper JD, Lansbury PT (1997) Models of amyloid seeding in Alzheimer's disease and scrapie: Mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Ann Rev Biochem 66:385-407
18. Christie RH, Bacskai BJ, Zipfel WR et al (2001) Growth arrest of individual senile plaques in a model of Alzheimer's disease observed by in vivo multiphoton microscopy. J Neurosci 21:858-864
19. Kuner P, Bohrmann B, Tjernberg LO et al (2000) Controlling polymerization of beta-amyloid and prion-derived protein with synthetic small molecular ligands. J Biol Chem 275:1673-1678